Revolution Medicines Income Statement (2019-2026) | RVMD

1Y3Y5Y7Y10YAll
Download Data
Income Statement Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Dec2024 Jun2025 Jun2026
Shares Outstanding (Entity) (Quarter)
214.34M
Revenue & cost
Revenue (Quarter)
12.09M11.55M10.03M12.66M8.75M10.13M8.70M1.10M9.46M7.58M9.12M3.36M15.33M7.01M3.82M0.74M
Operating items
Research & Development (Quarter)
394.92M
Amortization - Intangibles (Quarter)
0.30M
Wages, Salaries and Other (Quarter)
78.63M
Selling, General & Administrative (Quarter)
110.21M
Operating Expenses (Quarter)
505.13M
Operating Income (Quarter)
-505.13M
EBIT (Quarter)
-505.13M
Non-operating items
Interest & Investment Income (Quarter)
35.58M
Other Non Operating Income (Quarter)
-0.01M
Non Operating Income (Quarter)
-139.24M
Net income details
EBT (Quarter)
-644.37M
Tax Provisions (Quarter)
-0.68M-0.06M0.36M-0.30M-0.10M-3.87M4.19M-0.80M
Profit After Tax (Quarter)
-644.37M
Income from Continuing Operations (Quarter)
-644.37M
Consolidated Net Income (Quarter)
-644.37M
Income towards Parent Company (Quarter)
-644.37M
Preferred Dividend Payments (Quarter)
4.25M2.22M
Net Income towards Common Stockholders (Quarter)
-644.37M
Additional items
EPS (Basic) (Quarter)
-3.06
EPS (Diluted) (Quarter)
-3.06
Shares Outstanding (Quarter)
210.89M
Shares Outstanding (Diluted) (Quarter)
210.89M
EBITDA (Quarter)
-505.13M
Interest Expenses (Quarter)
2,696.55M
Tax Rate (Quarter)
3.340.21-1.070.400.183.44-2.600.41